A Tear Down Report
Of iPhone 7
A Patent Landscape Report
On Diamond Like Carbon
On Smart Parking
An Invalidation Search Report
on 4256/CHE/2012
A Sample Landscape Study on
5-Hydroxymethyl Furfural (HMF)
A Patent Valuation Report on
WO/2017/051547
A Patent Landscape Report on
Flexible Displays
BYD (Electric Vehicles)
Devising Patent Strategies from Long
Term Impact Standpoint
Rendering Sage Legal Advice
for Pro-Active Enforcement
Retrieving Clarity
from Complexity
Sensitively Creating
Sensible Intellectual Property
Khurana & Khurana, Advocates and IP Attorneys (K&K) is more than a full service Intellectual Property and Commercial Law firm. K&K was formed in the year 2007 with a very firm focus of providing end-to-end IP Prosecution/Litigation and Commercial Law services in a manner that is Corporate centric and follows stringent delivery practices that are consistent and are above defined quality standards. K&K works closely with its sister concern IIPRD, both of which supplement each other in order to provide end-to-end IP Legal and Commercialization/Licensing services to over 3000 Corporates. K&K is a team of over 150 professionals spread across 10 Offices (New Delhi, NCR, Pune, Mumbai, Indore, Hyderabad, Bangalore, Punjab, Chennai ) in India, and has strong rankings from Legal 500, MIP, IAM, Chambers, Asia IP, Global 100, Rsg, Niti Aayog, WIPR Leaders, Global Venture, ACQ5 among others.
Our team of IP Attorneys/Practitioners, having high level of technical and legal competence, gives us the right competitive edge and positioning, as a law firm focused on creating immense IP value for our clients. K&K through its experienced and qualified team of Attorneys/Practitioners, across Technology and Legal Domains, gives a rare synergy of legal opinion, out-of-box thinking for protection of ideas/IP's and entrepreneurial spirits to its client base. K&K earnestly believes that success comes only when one has a long-term perspective and this is why we concentrate on building long-term relationships through high level of client orientation.
K&K's critically focuses on a broad range of Technology Consulting and IP Research Services spanning all stages of IP Procurement, Management, and Enforcement. K&K has a diligent and earnest team of strong Patent, Commercial, and Legal Professionals who enable the firm to provide the complete spectrum of services starting from Market/Technology Research to Licensing/Commercialization to Litigation Support. K&K's more than 10 years of substantive experience has helped it gain a prominent name in the Industry as a reliance and trustworthy partner in the complete Research and Analytics Process.
IP Protection and Portfolio Management
Khurana & Khurana, Advocates and IP Attorneys has been established precisely to help corporate leverage anticipated business and economic value from its efficient creation, protection and enforcement of their Intellectual Properties. Khurana & Khurana has created a unique and strategic position for itself by giving End-to-End IP services to its clients from the inception stage of creation of IP to successful commercialization of the IP for fulfillment of desired business objectives. The role and importance of patent professionals in IP (intellectual property) portfolio management (IPM) are increasing becoming significant within business, academic, and legal entities.
IP Litigation and Enforcement
Khurana & Khurana has a legacy of over ten years in Patent Litigation and serves some of the leading Corporates for IP infringement matters. Our experience includes finding the potential infringers for the IP owners through due diligence and assessing the market for the same. For doing this, our firm has Patent/Trade Mark Attorneys/Practitioners who have advanced qualifications in varied technology domains and understand complete nuances of claim mapping and provisions of enforcement under different IP Laws.
Khurana & Khurana assists Corporates in maximizing opportunities from their IP portfolios through accurate legal opinions that ensure that all possible ways to solve a problem are identified and due-diligence of each way is put across in the right manner such that the client can take a judicious call on the way to proceed forward. K&K renders Prior art, Freedom to Operate, Validity, and Non-infringement opinions relating to a client's products and technologies. K&K also prepares a comprehensive IP Litigation Strategy before initiating with a legal suit to ensure that the clients understands the next steps clearly, sets its expectations, and is cognizant of the costs involved in the process.
Commercial Law Practice
Commercial law governs the broad areas of business, commerce and consumer transactions. Commercial law in India has developed rapidly over the years with the opening up approach towards FDI and WTO. It allows, so far as it can, Corporate or person to do business in the way they want and not require them to stick to forms that they may think to be outmoded. Thus, Commercial Law Practice is recognized as a very important and integral element of any corporate operation, and is gaining more and more importance.In this era of globalisation, sweeping changes in business strategies require Corporates to meet challenge of complying with commercial contract law for the smooth functioning of its business and commerce.
Domain Name Resolution Practice
The Internet Corporation for Assigned Names and Numbers (ICANN) is responsible for the administration of Top Level Domain Names. The Uniform Dispute Resolution Policy provides for the settlement of domain name disputes for the Generic Top Level Domains Name (GTLD) such as .com, .edu, .net, among others. The UDRP complaints may be filed with any of the ICANN accredited arbitration centres. UDRP also allows for the filing of the complaints at the jurisdictional civil court where the Registrant or the Registrar is located. Where the Registrar or the Registrant is located in India, the dispute may be resolved through legal action at the civil court.
Anti-Counterfeiting Practice
Attorneys at Khurana & Khurana have developed significant experience in the area of anti-counterfeiting, especially in FMCG, Pharmaceuticals, Apparels, Footwear, and Medical Devices product verticals, and can assist in devising a comprehensive strategy for curbing counterfeit products by outlining all possible risks and assumptions and mapping them with costs involved in each step taken so that a judicious and objective step can be taken by the client..
Core Practitioners/Team
Vinod Khurana Senior Partner and Trademark Attorney
Tarun Khurana Partner and Patent Attorney in Software/Electronics/Mechanical Group
Meenakshi Khurana Partner and Patent Attorney - Pharmaceutical Practice Group
Abhishek Pandurangi Partner and Patent Attorney - Chemical Practice Group
Mita Sheikh Principal Patent Associate - Pharmaceutical-Life Sciences Practice Group
Rajesh Jain Director - Patents
Hardeep Sodhi Associate Director - Patents
Gurmeet Kaur Nanda Principle Associate - Patents
Dr. Padmapriya Consultant - Pharmaceutical-Life Sciences Practice Group
Dr. Shikha Tejswi Senior Principal Associate
Lalit Suryavansi Principal Associate - Electronics/Telecom/Software Practice Group
Antony David Principal Associate - Pharmaceutical-Life Sciences Practice Group
Swapnil Sanap Associate Partner & Head of Pune Office
Paras Khurana Senior Associate - Software/Electronics/Mechanical Group
Tapan Shah Principal Associate - Pharmaceutical-Life Sciences Practice Group
Ankur Sehgal Senior Patent Attorney
Mohinder Vig Partner and Head - Trade Marks, Copyright-Media & Entertainment
Varun Khurana Head - Valuation Group
Parvez Kudrolli Senior Associate - Software/Electronics Practice Group
Vibhor Gupta Senior Associate - Litigation
Arindam Purkayastha Patent Attorney
Anuja Nair Senior Associate – Media & Entertainment-Litigation
Dr. Sanjeev Kumar Garg Senior Associate - Pharmaceutical-Life Sciences Practice Group
Syed Habeeb Ahmed Senior Associate - Pharmaceutical-Life Sciences Practice Group
Dhakshina Moorthy C Principal Associate - Pharmaceutical-Life Sciences Practice Group
Ankit Kumar Senior Associate - Patent Licensing/Commercialization
Abhijeet Deshmukh Associate Partner and Advocate- Commercial and Corporate Law Practice
Pradip Kumar Roy Principal Associate - Pharmaceutical-Life Sciences Practice Group
Injunctions Against Sell of Lingaliptin
Analysis of Boehringer Ingelheim Pharma GmbH v/s Tanmed Pharma and other orders Plaintiffs: Boehringer Ingelheim Pharma GmbH & Co. KG & Boehringer Ingelheim (India) Pvt.Ltd. ("the plaintiff"/"Boehringer") Defendant:Tanmed Pharma India Private Limited("the defendant") Coram: Dr. Justice G. Jayachandran Date of Judgment: 21st January 2020 Facts of the Case: The plaintiff is a multinational company involved … Continue reading Injunctions Against Sell of Lingaliptin
The Multidimensional Question Of 3 Dimensional Trademarks
Introduction The product market today is highly competitive. If a brand does not constantly evolve itself, it is at the danger of failing to satisfy its customers. To keep reinventing itself, it must ensure protection to the assets that bring value to the company. For this reason, it is important to give recognition to non-conventional … Continue reading The Multidimensional Question Of 3 Dimensional Trademarks
Protection of Well-Known Marks: WIPO Joint Recommendation
"What's in a name? That which we call a rose by any other name would smell as sweet"- Shakespeare In many countries, getting trademark registered is the only apparatus to obtain statutory rights. As an essential element to registration, some countries requires the owner of the trademark to use or make evident its intent to … Continue reading Protection of Well-Known Marks: WIPO Joint Recommendation
The Dichotomy of IPR Protection and Social Welfare- An Analysis of the Indian Patents Act with respect to the Pharmaceutical Industry
Introduction Intellectual Property Rights, in the simplest of terms, refer to rights over creation of the mind. In a world where knowledge economies are on the rise, IPR has become increasingly significant. Intellectual Property Rights entail several rights within its ambit- copyright, patent, geographical indication etc. In this article, we deal only with one form of … Continue reading The Dichotomy of IPR Protection and Social Welfare- An Analysis of the Indian Patents Act with respect to the Pharmaceutical Industry
Patent Application Refused On Grounds Of Insufficiency Of Disclosure
In a recent patent pre-grant opposition matter wherein Khurana and Khurana, Advocates and IP Attorneys (K&K) represented the Opponent, the patent application was refused mainly on grounds of Insufficiency of Disclosure as per Section 25(1)(g) of the Indian Patents Act, 1970 ("Patents Act"). This case re-confirms the role of sufficiency of disclosure or enablement during … Continue reading Patent Application Refused On Grounds Of Insufficiency Of Disclosure
Protecting the Patent Regime for Pharmaceutical Companies in India
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) provides for more extensive protection of intellectual property by the WTO members who signed the agreement. India signed the agreement and subsequently amended the Patents Act of 1970, in compliance with TRIPS in 2005. However, India, as a developing country, has been faced with the … Continue reading Protecting the Patent Regime for Pharmaceutical Companies in India
Comprehensive Study of Section 117A of The Patents Act, 1970
Introduction The Patents Act, 1970 (hereinafter referred to as Act) being a gallant enactment to encourage research & development and innovation and providing monopoly over intellectual creations came into force on 20th April 1972, supplanting the Indian Patents and Designs Act 1911. This enactment is currently in par with all the international arrangements as it gets … Continue reading Comprehensive Study of Section 117A of The Patents Act, 1970
Similar Trademark Issued For Different Items Does Not Amount To Breach Of Law
The long pending question in the field of Intellectual Property Rights, with respect to the Tademarks, was finally answered by the Supreme Court, when it ruled, in the case of Nandhini Deluxe v. Karnataka Co-Operative Milk Producers Federation Ltd.[1], that no law is violated or breached, if the two companies, with two different products, use … Continue reading Similar Trademark Issued For Different Items Does Not Amount To Breach Of Law
Post-mortem Personality Rights and their relevance in Jayalalithaa's Biopic Suit
"The nicest thing is to open newspapers and not to find yourself in them." – George Harrison Being a well-known personality could cost you your personality rights, at times. Living a life which requires you to be cautious of your every move is quite a difficult one. Being a celebrity comes with a lot of … Continue reading Post-mortem Personality Rights and their relevance in Jayalalithaa's Biopic Suit
The New Age Eugenics Of DNA Patenting
Abstract 'DNA Theft' is the new term employed to decipher the existing legal regime in the field of gene patenting. The oblivious nature of law has ceded transcending to a more flexible framework concerning the same. DNA is vested with a proprietary interest of ownership. 'Patenting gene' impinges the individual right to privacy. This paper … Continue reading The New Age Eugenics Of DNA Patenting
Extending Protection to Ideas; Breaking the Notion of Monopoly
An Idea can be defined as, "A concept which has not been put in a tangible form so as to be a subject of copyright but which may be a subject of protection by Contract."[1] The manifestation of ideas into words or any material form is called 'expressing' the idea.[2] The objective of the copyright … Continue reading Extending Protection to Ideas; Breaking the Notion of Monopoly
Draft Designs(Amendment) 2019
The Designs Act, 2000, is introduced with an object to protect and safeguard the original design of an article with the aim to reward the innovator for research and labour applied by him for the purpose to originate or evolve such a new and original industrial design.These industrial designs of the innovator, subject to the … Continue reading Draft Designs(Amendment) 2019